EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

The therapeutic potential of targeting cardiac RGS4

Giselle Del Calvo, Teresa Baggio Lopez, Anastasios Lymperopoulos iD

Therapeutic Advances in Cardiovascular Disease · 2023

DOI: 10.1177/17539447231199350 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Cardiovascular Disease, 2023. Verfasst von Giselle Del Calvo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences, Barry and Judy Silverman College of Phar…. Hauptthemen laut MEDLINE: RGS Proteins, Heart Diseases, Heart Failure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

G protein-coupled receptors (GPCRs) play pivotal roles in regulation of cardiac function and homeostasis. To function properly, every cell needs these receptors to be stimulated only when a specific extracellular stimulus is present, and to be silenced the moment that stimulus is removed. The regulator of G protein signaling (RGS) proteins are crucial for the latter to occur at the cell membrane, where the GPCR normally resides. Perturbations in both activation and termination of G protein signaling underlie numerous heart pathologies. Although more than 30 mammalian RGS proteins have been identified, each RGS protein seems to interact only with a specific set of G protein subunits and GPCR types/subtypes in any given tissue or cell type, and this applies to the myocardium as well. A large number of studies have provided substantial evidence for the roles various RGS proteins expressed in cardiomyocytes play in cardiac physiology and heart disease pathophysiology. This review summarizes the current understanding of the functional roles of cardiac RGS proteins and their implications for the treatment of specific heart diseases, such as heart failure and atrial fibrillation. We focus on cardiac RGS4 in particular, since this isoform appears to be selectively (among the RGS protein family) upregulated in human heart failure and is also the target of ongoing drug discovery efforts for the treatment of a variety of diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RGS ProteinsHeart DiseasesHeart FailureAnimalsHumansSignal TransductionHeartGTP-Binding ProteinsMammals

Stichwörter der Autor:innen

G protein-coupled receptorG proteinsarrhythmiasatrial fibrillationcardiac myocytecyclic AMPheart failureregulator of G protein signalingsignal transduction

Substanzen

RGS ProteinsGTP-Binding Proteins

Autor:innen und Institutionen

  • Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences, Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, USA.
  • Laboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences, Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, 3200 South University Drive, HPD (…

ORCID-Profile: Anastasios Lymperopoulos

Förderung

  • National Heart, Lung, and Blood Institute

Zitieren

APA

Del Calvo, G., Baggio Lopez, T., & Lymperopoulos, A. (2023). The therapeutic potential of targeting cardiac RGS4. Therapeutic Advances in Cardiovascular Disease. https://doi.org/10.1177/17539447231199350

Vancouver

Del Calvo G, Baggio Lopez T, Lymperopoulos A. The therapeutic potential of targeting cardiac RGS4. Therapeutic Advances in Cardiovascular Disease. 2023. doi:10.1177/17539447231199350

BibTeX
@article{DelCalvo2023,
  author = {Del Calvo, Giselle and Baggio Lopez, Teresa and Lymperopoulos, Anastasios},
  title = {The therapeutic potential of targeting cardiac RGS4},
  journal = {Therapeutic Advances in Cardiovascular Disease},
  year = {2023},
  doi = {10.1177/17539447231199350}
}
Kostenlos starten →